Celltech Details Phase III Trial Plans For CDP870 In Crohn's Jan. 7, 2004 By Aaron Lorenzo A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International)Read More
Celltech Details Phase III Trial Plans For CDP870 In Crohn's Jan. 7, 2004 By Aaron Lorenzo A Phase III program in Crohn's disease is under way to evaluate a compound being developed by Celltech Group plc. (BioWorld International)Read More
